Vascular Solutions (VASC) : Conestoga Capital Advisors reduced its stake in Vascular Solutions by 14.92% during the most recent quarter end. The investment management company now holds a total of 1,060,111 shares of Vascular Solutions which is valued at $45,404,554 after selling 185,972 shares in Vascular Solutions , the firm said in a disclosure report filed with the SEC on Jul 22, 2016.Vascular Solutions makes up approximately 3.30% of Conestoga Capital Advisors’s portfolio.
Other Hedge Funds, Including , New York State Teachers Retirement System boosted its stake in VASC in the latest quarter, The investment management firm added 300 additional shares and now holds a total of 9,899 shares of Vascular Solutions which is valued at $423,974.Thomson Horstmann Bryant Inc reduced its stake in VASC by selling 53,792 shares or 16.03% in the most recent quarter. The Hedge Fund company now holds 281,820 shares of VASC which is valued at $12,070,351. Vascular Solutions makes up approx 1.49% of Thomson Horstmann Bryant Inc’s portfolio.Eagle Asset Management Inc boosted its stake in VASC in the latest quarter, The investment management firm added 13,346 additional shares and now holds a total of 246,900 shares of Vascular Solutions which is valued at $10,589,541. Vascular Solutions makes up approx 0.07% of Eagle Asset Management Inc’s portfolio.Eqis Capital Management reduced its stake in VASC by selling 482 shares or 6.42% in the most recent quarter. The Hedge Fund company now holds 7,026 shares of VASC which is valued at $298,605. Vascular Solutions makes up approx 0.02% of Eqis Capital Management’s portfolio.Capstone Asset Management Co boosted its stake in VASC in the latest quarter, The investment management firm added 1,480 additional shares and now holds a total of 9,580 shares of Vascular Solutions which is valued at $417,975. Vascular Solutions makes up approx 0.01% of Capstone Asset Management Co’s portfolio.
Vascular Solutions closed down -0.34 points or -0.74% at $45.87 with 1,31,961 shares getting traded on Friday. Post opening the session at $46.12, the shares hit an intraday low of $45.62 and an intraday high of $46.8 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Vascular Solutions reported $0.33 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $0.30. The company had revenue of $41.19 million for the quarter, compared to analysts expectations of $41.07 million. The company’s revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.29 EPS.
Many Wall Street Analysts have commented on Vascular Solutions. Vascular Solutions was Downgraded by Sidoti to ” Neutral” on Jul 12, 2016.
Vascular Solutions Inc. is a medical device company which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products which consist of the D-Stat Dry hemostat to control surface bleeding D-Stat Flowable for preventing bleeding in subcutaneous pockets Accumed wrist positioning splints and Vasc Band inflatable compression bands and Vein products which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.